This inventor holds 3 USPTO granted patents. Top assignee: Regents of the University of Minnesota. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: Kanamata Reddy: Innovator in Therapeutic Compounds and Cancer Treatment
Introduction
Kanamata Reddy is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of anti-cancer agents. With a total of 3 patents, Reddy's work is recognized for its potential impact on cancer treatment.
Latest Patents
Reddy's latest patents include innovative therapeutic compounds that provide a compound of formula I or a salt thereof. These compounds are described in detail in the specification and are useful as anti-cancer agents. Another significant patent involves Aurora kinase inhibitors, which are compounds that serve as intermediates for preparing corresponding compounds useful for treating conditions associated with Aurora B kinase activity, such as cancer.
Career Highlights
Kanamata Reddy is affiliated with the Regents of the University of Minnesota, where he conducts his research and development. His work has been instrumental in advancing the understanding and treatment of cancer through innovative compounds.
Collaborations
Reddy collaborates with esteemed colleagues, including Ann M Bode and Zigang Dong, who contribute to his research efforts and enhance the impact of his inventions.
Conclusion
Kanamata Reddy's contributions to the field of therapeutic compounds and cancer treatment highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile